ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Fate Therapeutics (FATE)

Technical Analysis Report for USA stock FATE Fate Therapeutics. Dated: 16 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock FATE Fate Therapeutics then click here. or read Experts views on Fate Therapeutics or Forecast & share price targets of Fate Therapeutics

Fate Therapeutics Opened at 1.12 and Closed at: 1.09, which is -2.75% of previous session's close. It moved within a range of 1.08 and 1.19
The session was a Bearish session with an average volume of 1623000, which is 32.93% of previous session's volumes.

    Support for tomorrow is 1.03 and resistance for tomorrow is 1.14
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 1.05, 1.01 resistance for tomorrow's hourly charts is 1.16, 1.23

    10 Day SMA for Fate Therapeutics (FATE) is 1.1 and stock is trading below these levels. This is not a good sign for its short term trend

    20 Day SMA for Fate Therapeutics (FATE) is 1.07 and the stock is trading above these levels. This is a good sign for its mid term trend

    50 Day SMA for Fate Therapeutics (FATE) is 1.23 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

    100 Day SMA is 1.15 and the stock is trading below these levels. This is not a good sign for its long term trend

    200 Day SMA Fate Therapeutics is 1.13 and stock is trading below these levels. This is not a good sign for its long term trend

    20 DMA of Fate Therapeutics is at 1.07 and 200 DMA is at 1.13, while 50 DMA and 100 DMA are at 1.23 and 1.15 respectively

    Fate Therapeutics (FATE) moving average of 20 SMA is at 1.07 and 20 EMA is at 1.1

    Fate Therapeutics (FATE) moving average of 50 SMA is at 1.23 and 50 EMA is at 1.15

    Fate Therapeutics (FATE) moving average of 100 SMA is at 1.15 and 100 EMA is at 1.25

    Fate Therapeutics (FATE) moving average of 200 SMA is at 1.13 and 200 EMA is at 1.46

    Fate Therapeutics has performed better than Merck Company in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Glaxosmithkline Plc in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Zynex Inc in short term. Holding Fate Therapeutics could be a better choice for now!

    Twist Bioscience has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Twist Bioscience, about 12.87% more returns!

    Fate Therapeutics has performed better than Uniqure N in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Minerva Neurosciences in short term. Holding Fate Therapeutics could be a better choice for now!

    Neurocrine Biosciences has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 0.43% more returns!

    Inmune Bio has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Inmune Bio, about 19.14% more returns!

    Fate Therapeutics has performed better than Idexx Laboratories in short term. Holding Fate Therapeutics could be a better choice for now!

    Icon Plc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Icon Plc, about 6.45% more returns!

    Fate Therapeutics has performed better than Halozyme Therapeutics in short term. Holding Fate Therapeutics could be a better choice for now!

    Gossamer Bio has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Gossamer Bio, about 10.63% more returns!

    Fate Therapeutics has performed better than Fonar Corporation in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Denali Therapeutics in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Cytokinetics Incorporated in short term. Holding Fate Therapeutics could be a better choice for now!

    Cerus Corporation has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Cerus Corporation, about 38.11% more returns!

    Fate Therapeutics has performed better than Benitec Biopharma in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics Technical analysis of indicators

    Price action analysis of Fate Therapeutics (FATE) based on a short term time period is neutral. A longer time frame might give a better analysis.

    ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

    MACD generated a BUY signal for Fate Therapeutics in short term but the buy signal is initial and weak.

    Fate Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

    Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

    CCI has generated a SELL signal for Fate Therapeutics in short term but SELL signal is weak.

    RSI is generating a SELL signal in short term but selling is losing momentum.

    MRSI is in negative zone. This is the SELL zone

    Stock of Fate Therapeutics is picking up buying momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 1.1 and Fate Therapeutics FATE stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

    People seem to be coming out and selling the Fate Therapeutics FATE stock. Volume based technical analysis of Fate Therapeutics FATE stock is negative.

    Fate Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for USA stock FATE Fate Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And FATE Experts View which covers a lot of information including buying and selling signals

    FATE future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Fate Therapeutics or View Candle Stick Charts here

    Chart Fate Therapeutics (FATE)  Technical (Analysis) Reports Fate Therapeutics [

    Videos related to: Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

    Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

    Hindi Video Most Important Stock Market Video. No Success Without This Formula

    Fate Therapeutics (FATE)  Technical (Analysis) Reports Fate Therapeutics [

     

    Back to top